HRC Ledger

Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC

NewCloses September 10, 2026clinicalOpportunity
Our scope is to acquire specific FDA-approved infectious disease and oncology assays formulated as single-use test cartridges and reagents that are equal to and/or compatible to what is currently being used on the VA owned instrument/analyzer. Required rapid molecular assays include targets for C. difficile, SARS-CoV-2 with Influenza A & B and RSV, Strep A, MTB IVD – Mycobacterium tuberculosis with Rif, MVP-Multiplex Vaginal Panel, GI Panel, MRSA Carba-R, Norovirus, BCR-ABL, FII & FV and vanA PCR. The kit storage temperature should be 2 – 28°C and not require refrigeration. Time and date of delivery to be determined by the PSHCS Microbiology Department.
Build pursuit package

Key dates

Response due

September 10, 2026

Posted
August 19, 2026

Details

Buyer
260-NETWORK Contract Office 20 (36C260)
Agency
260-NETWORK Contract Office 20 (36C260)
Buyer type
Federal
Jurisdiction
the United States (US)
Category
Clinical
Value
Set-aside
No Set aside used
NAICS
325413
PSC
6515
Source
sam.gov

Organization

Source: Provider universe

Not matched to a provider record yet.

Buying history

Source: Solicitation records
  • Records90 total
  • Opportunities / awards26 / 8
  • Value range$465,117 – $9,000,000
  • ActiveApril 28, 2026 – August 19, 2026

What they buy

  • Administrative (48)
  • Clinical (42)

Set-asides used

  • Small Business Set Aside - Total (25)
  • No Set aside used (23)

Financial highlights

Source: IRS Form 990

No 990 filing on record.

Who holds their work today

Source: Solicitation records · awards

No awards on record for this buyer.

What they're trying to solve

Source: AI-generated

No brief written for this buyer yet.

Also open from this buyer

Source: Solicitation records

Ways to meet this buyer

Source: Solicitation records · event notices

Upcoming

No upcoming events on record.

View source document →

Source link on sam.gov.